tRNA Synthetase Fidelity Mechanisms
tRNA 合成酶保真机制
基本信息
- 批准号:8460160
- 负责人:
- 金额:$ 30.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-01 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAddressAmino AcidsAmino Acyl-tRNA SynthetasesAminoacylationAnti-Infective AgentsAntibiotic ResistanceAntibioticsBiochemicalBiochemistryBiologicalCellsComplexCustomDataDefectDevelopmentEngineeringEnsureEnzymesFamilyFluorescenceHealthHumanHydrolysisIndividualInterdisciplinary StudyInvestigationLeucineLifeLinkMapsModelingMolecularMolecular BiologyNatureOrganismOutcomePathway interactionsPharmacologic SubstancePhysiologicalProtein BiosynthesisProteinsRNA-Protein InteractionReactionResearchResolutionRibosomesRoentgen RaysSiteSocial WelfareSpecificityStructureTechnologyTherapeuticTransfer RNATransfer RNA AminoacylationTranslationsWorkX-Ray Crystallographyadenylateantimicrobial drugbasecomputational chemistrydeacylationdesignenzyme pathwayin vivo Modelinnovationinsightinterdisciplinary approachleucine-tRNAmolecular dynamicsmutantnervous system disordernovelpolypeptideresearch studysingle moleculesingle-molecule FRETtool
项目摘要
DESCRIPTION (provided by applicant):
The aminoacyl-tRNA synthetases (aaRSs) comprise a family of up to twenty two enzymes that are essential to every living organism. Each enzyme recognizes a single cognate amino acid and covalently attaches it to the correct tRNA. The "charged" tRNA then transfers the amino acid at the ribosome for specific incorporation into the growing polypeptide chain. The fidelity of protein synthesis is completely dependent on accurate substrate recognition by the aaRSs, which guards against neurological disease. Some aaRSs have developed editing mechanisms to correct misactivated amino acids. These editing aaRSs clear the wrong amino acid by hydrolysis of either of two substrates-misactivated aminoacyl-adenylates ("pre-transfer" of amino acid to tRNA) or misacylated aa-tRNA ("post-transfer"). Although one of these mechanisms may dominate, most aaRSs that edit appear to operate by a mixture of pre-and post-transfer editing, which has historically complicated investigations to determine their respective molecular basis. New models for leucyl-tRNA synthetase (LeuRS) have been developed to isolate pre-transfer editing activities for detailed mechanistic investigations. In addition, pre-transfer editing can be dependent on tRNA. It is hypothesized that tRNA translocation between the synthetic and editing domains controls the enzyme's pathway choice between aminoacylation, post-transfer editing, and pre-transfer editing. This proposal outlines an interdisciplinary research plan that combines X-ray crystallography, computation, single molecule flourescence, biochemical, and molecular biology approaches to investigate tRNA translocation and the molecular basis of the enzyme- tRNA transition that forms stable aminoacylation and editing complexes. It will also characterize pre-transfer editing and its physiological impact on the cell. A detailed understanding of editing mechanisms will benefit ongoing pharmaceutical research that capitalizes upon aaRSs, especially the LeuRS editing site, as targets for antibiotic development. It will also enable re-engineering of aaRSs to activate alternate amino acids for incorporation into custom-designed proteins. These novel proteins could be used as therapeutics or tools in medicinal and technological applications.
描述(由申请人提供):
氨基酰-tRNA合成酶(AARs)包括一个多达22种酶的家族,这些酶对每个活着的有机体都是必不可少的。每种酶识别一种同源氨基酸,并将其共价连接到正确的tRNA上。“带电的”tRNA然后转移核糖体上的氨基酸,以特定的方式并入不断增长的多肽链。蛋白质合成的保真度完全依赖于AARS对底物的准确识别,AARS可以预防神经疾病。一些AARS已经开发了编辑机制来纠正未被激活的氨基酸。这些编辑的AARs通过两种底物中的任何一种的水解来清除错误的氨基酸--失活的氨基酰基腺苷(将氨基酸“预转移”为tRNA)或错酰化的AA-tRNA(“转移后”)。尽管这些机制中的一种可能占主导地位,但大多数编辑的AARS似乎是通过转移前和转移后编辑的混合来操作的,这在历史上需要复杂的研究来确定它们各自的分子基础。亮氨酰-tRNA合成酶(Leucyl-tRNA Synthetase,LEUR)的新模型已经被开发出来,用于分离转移前编辑活动,以便进行详细的机制研究。此外,转移前编辑可以依赖于tRNA。假设tRNA在合成域和编辑域之间的移位控制着酶在氨酰化、转移后编辑和转移前编辑之间的路径选择。这项建议概述了一个跨学科的研究计划,它结合了X射线结晶学、计算、单分子荧光、生化和分子生物学的方法,以研究tRNA易位和形成稳定的氨基酰化和编辑络合物的酶-tRNA转变的分子基础。它还将描述传输前编辑及其对细胞的生理影响。对编辑机制的详细了解将有助于正在进行的药物研究,这些研究利用AARS,特别是LEURS编辑站点,作为抗生素开发的目标。它还将使AARs能够重新设计,以激活替代氨基酸,并将其整合到定制设计的蛋白质中。这些新的蛋白质可以作为医疗和技术应用中的治疗或工具。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUSAN A MARTINIS其他文献
SUSAN A MARTINIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUSAN A MARTINIS', 18)}}的其他基金
FUNCTIONAL DIVERGENCE OF A UNIQUE C-TERMINAL DOMAIN OF LEUCYL-TRNA SYNTHETASE
亮氨酰-TRNA 合成酶独特 C 端结构域的功能差异
- 批准号:
7357995 - 财政年份:2006
- 资助金额:
$ 30.15万 - 项目类别:
Leucyl-tRNA Synthetase Assisted Splicing Mechanisms
亮氨酰-tRNA 合成酶辅助剪接机制
- 批准号:
6320999 - 财政年份:2001
- 资助金额:
$ 30.15万 - 项目类别:
Leucyl-tRNA Synthetase Assisted Splicing Mechanisms
亮氨酰-tRNA 合成酶辅助剪接机制
- 批准号:
6735679 - 财政年份:2001
- 资助金额:
$ 30.15万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 30.15万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 30.15万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 30.15万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 30.15万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 30.15万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 30.15万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 30.15万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 30.15万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 30.15万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 30.15万 - 项目类别:
Research Grant